What is Johnson & Johnson (JNJ) stock EPS forecast? Johnson & Johnson beatanalysts’ expectations during the last earnings period by2.51%. Johnson & Johnson reported earnings of $ 2.04 per share on Jan 22, 2025, while the forecasted EPS was $ 1.99. ...
$359.99B Enterprise Value$375.44B Total Cash (Recent Filing)$20.30B Total Debt (Recent Filing)$35.75B Price to Earnings (P/E)24.7 Beta0.25 Next Earnings Jan 22, 2025 EPS Estimate $2.02 Last Dividend Ex-Date Nov 26, 2024 Dividend Yield3.28% ...
Cost per Share $ End Date End Date Price $ Dividend Growth Growth RateYield on Cost 1 Year4.5%3.32% 3 Year5.4%3.72% 5 Year5.6%4.18% 10 Year6%5.69% Dividend Yield History GoodDividend Yield % : Close to 10-year high This is the historical trailing annual dividend yield of Johnson & Jo...
Explore Johnson & Johnson stock dividend history, dividend yield range, next JNJ dividend date, and Johnson & Johnson stock dividend forecast Free SpinsTrade Crypto JNJ Dividend Summary The last Johnson & Johnson (JNJ) dividend payout was $ 1.24 per JNJ share on February 18, 2025, resulting...
JNJ January 2023 daily chart In the lastanalysis, we predicted that the JNJ share price will continue to fall. The ideal was to make a zigzag ABC correction that would complete wave (Y) of ((Y)) and thus wave II to continue the rally. Well, the market fell building the expected struc...
Additionally, consensus estimates forecast an EPS of around $10.00. Although this represents a year-over-year increase of just under 1%, indicating potential profitability headwinds in the second half of the year, it nonetheless reflects another record figure for the healthcare giant. This estimate ...
If you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best...
Hi. Good morning. Thanks for taking the questions. Joe, I was hoping that, just as we’re thinking about 2022, and you encouraging The Street to exclude COVID vaccine revenues from our forecast, I was hoping just to better understand the COVID-19 vaccine margin impact in 2021. It seems...
More importantly, JNJ boosted its 2019 sales forecast, excluding currency movement, to $82.4 billion to $83.2 billion, from an original range of $82 billion to $82.8 billion and the stock still declined. Credit Suisse resumed coverage of JNJ today with a $156 price target, implying significant...
Price to Book (P/B)N/A Price to Sales (P/S)4.03 Price to Cash Flow (P/CF)11.10 P/FCF Ratio12.40 Enterprise Value/Market Cap1.15 Enterprise Value/RevenueN/A Enterprise Value/Gross Profit6.95 Enterprise Value/Ebitda13.80 Forecast 1Y Price Target$167.50 Price Target Upside9.39% Upside Rating...